Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 70 points (-0.4%) at 16,940 as of Monday, Oct. 6, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,489 issues advancing vs. 1,550 declining with 137 unchanged.

The Materials & Construction industry currently sits down 0.4% versus the S&P 500, which is down 0.3%. On the negative front, top decliners within the industry include Sherwin-Williams ( SHW), down 0.6%, and Weyerhaeuser ( WY), down 0.6%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Cemex SAB de CV ( CX) is one of the companies pushing the Materials & Construction industry higher today. As of noon trading, Cemex SAB de CV is up $0.15 (1.2%) to $12.75 on average volume. Thus far, 3.7 million shares of Cemex SAB de CV exchanged hands as compared to its average daily volume of 7.8 million shares. The stock has ranged in price between $12.67-$12.87 after having opened the day at $12.69 as compared to the previous trading day's close of $12.60.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

CEMEX, S.A.B. de C.V. produces, markets, distributes, and sells cement, ready-mix concrete, clinker, aggregates, and other construction materials for home construction and concrete pavement applications. Cemex SAB de CV has a market cap of $15.0 billion and is part of the industrial goods sector. Shares are up 6.5% year-to-date as of the close of trading on Friday. Currently there are 8 analysts who rate Cemex SAB de CV a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates Cemex SAB de CV as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year and impressive record of earnings per share growth. However, as a counter to these strengths, we find that the company's profit margins have been poor overall. Get the full Cemex SAB de CV Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Lennar ( LEN) is up $0.54 (1.4%) to $40.39 on average volume. Thus far, 1.3 million shares of Lennar exchanged hands as compared to its average daily volume of 2.9 million shares. The stock has ranged in price between $40.02-$40.57 after having opened the day at $40.14 as compared to the previous trading day's close of $39.85.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Lennar Corporation, together with its subsidiaries, is engaged in homebuilding activities in the United States. Lennar has a market cap of $6.8 billion and is part of the industrial goods sector. Shares are up 0.7% year-to-date as of the close of trading on Friday. Currently there are 6 analysts who rate Lennar a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Lennar as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, compelling growth in net income, increase in stock price during the past year, impressive record of earnings per share growth and notable return on equity. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Lennar Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, DR Horton ( DHI) is up $0.26 (1.2%) to $20.98 on light volume. Thus far, 1.6 million shares of DR Horton exchanged hands as compared to its average daily volume of 6.0 million shares. The stock has ranged in price between $20.86-$21.15 after having opened the day at $20.88 as compared to the previous trading day's close of $20.73.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

D.R. Horton, Inc. operates as a homebuilding company. It is engaged in the acquisition and development of land; and construction and sale of residential homes in 27 states and 78 markets in the United States under the D.R. Horton, America's Builder, Emerald Homes, and Breland Homes. DR Horton has a market cap of $7.5 billion and is part of the industrial goods sector. Shares are down 7.1% year-to-date as of the close of trading on Friday. Currently there are 9 analysts who rate DR Horton a buy, 1 analyst rates it a sell, and 4 rate it a hold.

TheStreet Ratings rates DR Horton as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full DR Horton Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the materials & construction industry could consider SPDR S&P Homebuilders ETF ( XHB) while those bearish on the materials & construction industry could consider ProShares Short Basic Materials Fd ( SBM).

null